Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Drysdale

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 11, 2005
3-(5-Chloro-2,4-dihydroxyphenyl)-pyrazole-4-carboxamides as inhibitors of the Hsp90 molecular chaperonePaul A Brough, Xavier Barril, Mandy Beswick, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 5, 2000
The carbenoid approach to peptide synthesisR T Buck, P A Clarke, D M Coe, et al.
Molecular Cancer Therapeutics|July 5, 2006
Preclinical pharmacokinetics and metabolism of a novel diaryl pyrazole resorcinol series of heat shock protein 90 inhibitorsNicola F Smith, Angela Hayes, Karen James, et al.
Oncotarget|October 6, 2015
Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug designAndrew J Massey, Stephen Stokes, Helen Browne, et al.
Breast Cancer Research : BCR|April 24, 2008
NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer modelsMichael Rugaard Jensen, Joseph Schoepfer, Thomas Radimerski, et al.
Molecular Cancer Therapeutics|April 8, 2010
Preclinical antitumor activity of the orally available heat shock protein 90 inhibitor NVP-BEP800Andrew J Massey, Joseph Schoepfer, Paul A Brough, et al.
Journal of Medicinal Chemistry|June 25, 2005
Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based designBrian W Dymock, Xavier Barril, Paul A Brough, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2006
4-Amino derivatives of the Hsp90 inhibitor CCT018159Xavier Barril, Mandy C Beswick, Adam Collier, et al.
Journal of Molecular Biology|April 21, 2004
Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNAAlastair I H Murchie, Ben Davis, Catherine Isel, et al.
Analytical Biochemistry|February 8, 2006
A fluorescence polarization assay for inhibitors of Hsp90R Howes, X Barril, B W Dymock, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|October 11, 2005
3-(5-Chloro-2,4-dihydroxyphenyl)-pyrazole-4-carboxamides as inhibitors of the Hsp90 molecular chaperonePaul A Brough, Xavier Barril, Mandy Beswick, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 5, 2000
The carbenoid approach to peptide synthesisR T Buck, P A Clarke, D M Coe, et al.
Molecular Cancer Therapeutics|July 5, 2006
Preclinical pharmacokinetics and metabolism of a novel diaryl pyrazole resorcinol series of heat shock protein 90 inhibitorsNicola F Smith, Angela Hayes, Karen James, et al.
Oncotarget|October 6, 2015
Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug designAndrew J Massey, Stephen Stokes, Helen Browne, et al.
Breast Cancer Research : BCR|April 24, 2008
NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer modelsMichael Rugaard Jensen, Joseph Schoepfer, Thomas Radimerski, et al.
Molecular Cancer Therapeutics|April 8, 2010
Preclinical antitumor activity of the orally available heat shock protein 90 inhibitor NVP-BEP800Andrew J Massey, Joseph Schoepfer, Paul A Brough, et al.
Journal of Medicinal Chemistry|June 25, 2005
Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based designBrian W Dymock, Xavier Barril, Paul A Brough, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2006
4-Amino derivatives of the Hsp90 inhibitor CCT018159Xavier Barril, Mandy C Beswick, Adam Collier, et al.
Journal of Molecular Biology|April 21, 2004
Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNAAlastair I H Murchie, Ben Davis, Catherine Isel, et al.
Analytical Biochemistry|February 8, 2006
A fluorescence polarization assay for inhibitors of Hsp90R Howes, X Barril, B W Dymock, et al.
Pageof 7